Literature DB >> 29484461

[Long-term changes in multimodal intensive tinnitus therapy : A 5‑year follow-up. German version].

P Brüggemann1, J Otto1, N Lorenz1, S Schorsch1, A J Szczepek2, B Böcking1, B Mazurek3.   

Abstract

BACKGROUND: We present 5‑year follow-up data for tinnitus-specific and comorbid depressive symptoms as well as stress-related outcome variables of an intensive multimodal 7‑day tinnitus therapy.
METHOD: Tinnitus burden (Tinnitus Questionnaire), stress (Perceived Stress Questionnaire), and depressive symptomatology (General Depression Scale) were measured at the 5‑year follow-up after a multimodal intensive 7‑day intervention. In all, 94 patients participated in the study.
RESULTS: All outcome variables showed significant improvement at the end of the 7‑day intensive treatment. These effects remained significant after 5 years.
CONCLUSION: The results of the present study support the effectiveness of the 7‑day multimodal intensive therapy for tinnitus. Posttreatment improvements were related to both tinnitus burden as well as stress and depressive symptoms and were maintained at the 5‑year follow-up.

Entities:  

Keywords:  Depressive symptoms; Multimodal treatment; Outcome; Stress; Tinnitus

Mesh:

Year:  2018        PMID: 29484461     DOI: 10.1007/s00106-017-0462-5

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  31 in total

Review 1.  Tinnitus.

Authors:  David Baguley; Don McFerran; Deborah Hall
Journal:  Lancet       Date:  2013-07-02       Impact factor: 79.321

2.  Assessing audiological, pathophysiological, and psychological variables in chronic tinnitus: a study of reliability and search for prognostic factors.

Authors:  W Hiller; G Goebel
Journal:  Int J Behav Med       Date:  1999

3.  Psychological comorbidity in patients with chronic tinnitus: analysis and comparison with chronic pain, asthma or atopic dermatitis patients.

Authors:  N Zirke; C Seydel; A J Szczepek; H Olze; H Haupt; B Mazurek
Journal:  Qual Life Res       Date:  2012-03-20       Impact factor: 4.147

4.  Specialised treatment based on cognitive behaviour therapy versus usual care for tinnitus: a randomised controlled trial.

Authors:  Rilana F F Cima; Iris H Maes; Manuela A Joore; Dyon J W M Scheyen; Amr El Refaie; David M Baguley; Lucien J C Anteunis; Gerard J P van Breukelen; Johan W S Vlaeyen
Journal:  Lancet       Date:  2012-05-26       Impact factor: 79.321

Review 5.  Retraining therapy for chronic tinnitus. A critical analysis of its status.

Authors:  B Kroener-Herwig; E Biesinger; F Gerhards; G Goebel; K Verena Greimel; W Hiller
Journal:  Scand Audiol       Date:  2000

Review 6.  A multidisciplinary systematic review of the treatment for chronic idiopathic tinnitus.

Authors:  Hans-Peter Zenner; Wolfgang Delb; Birgit Kröner-Herwig; Burkhard Jäger; Ingrid Peroz; Gerhard Hesse; Birgit Mazurek; Gerhard Goebel; Christian Gerloff; Regina Trollmann; Eberhard Biesinger; Harald Seidler; Berthold Langguth
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-12-19       Impact factor: 2.503

Review 7.  Cognitive behavioural therapy for tinnitus.

Authors:  Pablo Martinez-Devesa; Rafael Perera; Megan Theodoulou; Angus Waddell
Journal:  Cochrane Database Syst Rev       Date:  2010-09-08

Review 8.  Frontostriatal Gating of Tinnitus and Chronic Pain.

Authors:  Josef P Rauschecker; Elisabeth S May; Audrey Maudoux; Markus Ploner
Journal:  Trends Cogn Sci       Date:  2015-10       Impact factor: 20.229

Review 9.  Systematic review and meta-analyses of randomized controlled trials examining tinnitus management.

Authors:  Derek J Hoare; Victoria L Kowalkowski; Sujin Kang; Deborah A Hall
Journal:  Laryngoscope       Date:  2011-06-10       Impact factor: 3.325

Review 10.  Genetics of Tinnitus: An Emerging Area for Molecular Diagnosis and Drug Development.

Authors:  Jose A Lopez-Escamez; Thanos Bibas; Rilana F F Cima; Paul Van de Heyning; Marlies Knipper; Birgit Mazurek; Agnieszka J Szczepek; Christopher R Cederroth
Journal:  Front Neurosci       Date:  2016-08-19       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.